Tel Aviv and New York -- October 22, 2020 – G Medical Innovations Holdings Ltd. (“GMed”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, today announced that it has filed a registration statement on Form F-1 with the United States Securities and Exchange Commission (“SEC”) relating to the proposed initial public offering of its ordinary shares. Application has been made for listing the ordinary shares on the Nasdaq Global Market under the proposed ticker symbol “GMVD.”
The proposed US$30,000,000 offering (not including the underwriters’ over-allotment option) has a proposed price range of between US$5.00 and US$7.00 per share. The offering is subject to market conditions, and there can be no assurance as to whether the offering may be completed, or as to the actual size, price or other terms of the offering.
Boustead Securities, LLC and Fosun Hani Securities Limited are acting as co-lead underwriters for GMed’s proposed offering.
The offering is being made only by means of a prospectus. Copies of the prospectus relating to this offering may be obtained from: Boustead Securities, LLC, 6 Venture, Suite 395, Irvine, CA 92618 USA, Attn: Prospectus Department, telephone: +1 (949) 502-4408, or by email at offerings@boustead1828.com; or Fosun Hani Securities Limited, Suite 2101-2105, 21/F, Champion Tower, 3 Garden Road, Central, Hong Kong, Attn: Prospectus Department, telephone: +852 2979 6988, or by email at project.gmed@fosunhani.com; or copies may also be obtained by visiting EDGAR on the SEC’s website, at www.sec.gov.
A registration statement on Form F-1 relating to the proposed offering has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
G Medical Innovations Holdings LTD Contact:
Brendan Dekauwe, Director
CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.
